Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jaap Twisk, Donald L. Gillian-Daniel, Angie Tebon, Lin Wang, P. Hugh R. Barrett, Alan D. Attie
Published in Volume 105, Issue 4
J Clin Invest. 2000; 105(4):521–532 doi:10.1172/JCI8623
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0008623
Figure 7

Model of apoB secretion and degradation. Amino acid incorporation into increasingly longer apoB nascent chains is depicted. As apoB transits the secretory pathway, presecretory degradation occurs via both LDL receptor–dependent and –independent means that are either rapid or slow. The nascent lipoprotein particle ultimately reaches the cell surface, at which point the LDL receptor can mediate its reuptake; this results in internalization and subsequent turnover of apoB. This final degradation pathway is inhibited by addition of heparin.